학술논문
Role of the cAMP-PKA-NF-κB pathway in Mucin1 over-expression in A549 cells during Respiratory syncytial virus infection
Document Type
Academic Journal
Author
Source
BMC Infectious Diseases. November 30, 2023, Vol. 23 Issue 1
Subject
Language
English
ISSN
1471-2334
Abstract
Author(s): Yingkang Jin[sup.1], Dongwei Zhang[sup.1], Kuimiao Deng[sup.1], Peiqiong Wu[sup.1], Diyuan Yang[sup.1], Zhiwei Xie[sup.1], Wenjun Qiu[sup.1] and Guangyuan Yu[sup.1] Introduction Respiratory syncytial virus (RSV) is the most common pathogen associated with [...]
Respiratory syncytial virus (RSV) is the most common pathogen associated with acute lower respiratory tract infections in infants and young children worldwide. RSV commonly presents as bronchiolitis in young children; however, it can sometimes progress to pneumonia, respiratory failure, apnoea and even death. Although mucin1 (MUC1), a type of transmembrane glycoprotein present on airway epithelial surfaces, plays a crucial anti-inflammatory role in airway infections; however, its roles in RSV-associated acute lower respiratory tract infections have rarely been explored. In this study, we first revealed very high MUC1 protein levels in the exacerbation phase in sputum samples from children with RSV bronchiolitis. Because MUC1 is the downstream target of tumour necrosis factor-alpha (TNF-[alpha]) in RSV-infected A549 cells, we observed the inhibition of NF-κB activity, main downstream signalling of TNF-[alpha] and remarkably reduced levels of MUC1 in RSV-infected and TNF-[alpha] treated A549 cells. Furthermore, the cyclic adenosine monophosphate (cAMP) analogue (dbcAMP) downregulated the protein levels of p-IκB[alpha] and MUC1 in TNF-[alpha]-treated A549 cells. By contrast, a protein kinase A inhibitor (KT5720) up-regulated the levels of those proteins. dbcAMP and KT5720 had the same effects on MUC1 protein levels in RSV-infected A549 cells. In conclusion, we found that the cAMP-PKA-NF-κB pathway may play a role in the regulation of MUC-1 over-expression during RSV infection. Keywords: Respiratory syncytial virus, Mucin 1, cAMP, Protein kinase A, NF-κB
Respiratory syncytial virus (RSV) is the most common pathogen associated with acute lower respiratory tract infections in infants and young children worldwide. RSV commonly presents as bronchiolitis in young children; however, it can sometimes progress to pneumonia, respiratory failure, apnoea and even death. Although mucin1 (MUC1), a type of transmembrane glycoprotein present on airway epithelial surfaces, plays a crucial anti-inflammatory role in airway infections; however, its roles in RSV-associated acute lower respiratory tract infections have rarely been explored. In this study, we first revealed very high MUC1 protein levels in the exacerbation phase in sputum samples from children with RSV bronchiolitis. Because MUC1 is the downstream target of tumour necrosis factor-alpha (TNF-[alpha]) in RSV-infected A549 cells, we observed the inhibition of NF-κB activity, main downstream signalling of TNF-[alpha] and remarkably reduced levels of MUC1 in RSV-infected and TNF-[alpha] treated A549 cells. Furthermore, the cyclic adenosine monophosphate (cAMP) analogue (dbcAMP) downregulated the protein levels of p-IκB[alpha] and MUC1 in TNF-[alpha]-treated A549 cells. By contrast, a protein kinase A inhibitor (KT5720) up-regulated the levels of those proteins. dbcAMP and KT5720 had the same effects on MUC1 protein levels in RSV-infected A549 cells. In conclusion, we found that the cAMP-PKA-NF-κB pathway may play a role in the regulation of MUC-1 over-expression during RSV infection. Keywords: Respiratory syncytial virus, Mucin 1, cAMP, Protein kinase A, NF-κB